Document Detail


Differentiating pulmonary arterial and pulmonary venous hypertension and the implications for therapy.
MedLine Citation:
PMID:  21091615     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Pulmonary arterial and pulmonary venous hypertension develop from distinctly different etiologies. Pulmonary arterial hypertension (PAH), or Group 1 pulmonary hypertension (PH), is a precapillary PH that arises idiopathically or as the result of a divergent array of causes, including connective tissue disease. Pulmonary venous hypertension (PVH), or Group 2 PH, primarily manifests as a postcapillary PH in the setting of left heart failure or valvular disease. A subset of PVH patients, however, develop a reactive precapillary component of PH that mimics PAH. These patients can be misdiagnosed as having Group 1 PH by 2-dimensional echocardiography and are sometimes treated as such, which leads to exacerbation of heart failure. Therefore, 2-dimensional or Doppler echocardiography alone cannot be used to differentiate between these two classifications of PH. This highlights the need for right heart catheterization in the clinical assessment and diagnostic work-up of PH. The combination of imaging and invasive hemodynamic assessment by right heart catheterization provides the best diagnostic approach to ensure proper delineation of pulmonary arterial and pulmonary venous hypertension, and in turn leads to appropriate treatment.
Authors:
Sina Dadfarmay; Robert Berkowitz; Bernard Kim; Rama Bindu Manchikalapudi
Related Documents :
15249495 - Surgical treatments/interventions for pulmonary arterial hypertension: accp evidence-ba...
9438445 - Right ventricular regional function using mr tagging: normals versus chronic pulmonary ...
17583185 - A review of sitaxsentan sodium in patients with pulmonary arterial hypertension.
12727925 - Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hyperten...
16549345 - Investigating suspected pulmonary embolism during pregnancy.
8937515 - The vascular endothelial barrier--selective retention of lipoproteins.
Publication Detail:
Type:  Journal Article     Date:  2010-10-21
Journal Detail:
Title:  Congestive heart failure (Greenwich, Conn.)     Volume:  16     ISSN:  1751-7133     ISO Abbreviation:  Congest Heart Fail     Publication Date:    2010 Nov-Dec
Date Detail:
Created Date:  2010-11-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9714174     Medline TA:  Congest Heart Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  287-91     Citation Subset:  IM    
Copyright Information:
© 2010 Wiley Periodicals, Inc.
Affiliation:
Heart Failure and Pulmonary Hypertension Program, Heart and Vascular Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA. zerangi@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Reverse or inverted takotsubo cardiomyopathy (reverse left ventricular apical ballooning syndrome) p...
Next Document:  Individual and joint associations of obesity and physical activity on the risk of heart failure.